Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Epigenetics and Nuclear Signaling Transcription Domain Families Zinc Finger

Anti-PML+RARA Fusion antibody (ab43152)

Price and availability

184 272 ₸

Availability

Order now and get it on Thursday February 25, 2021

Anti-PML+RARA Fusion antibody (ab43152)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to PML+RARA Fusion
  • Suitable for: WB
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Recombinant Human PPAR delta protein (ab81806)
Corticosterone, endogenous steroid hormone (ab143597)
Product image
Anti-Bcl6 antibody [SP155] - C-terminal (ab183308)
Product image
Recombinant Human Steroidogenic Factor 1/SF-1 protein (ab114599)

Overview

  • Product name

    Anti-PML+RARA Fusion antibody
  • Description

    Rabbit polyclonal to PML+RARA Fusion
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human PML+RARA Fusion aa 500-600 conjugated to keyhole limpet haemocyanin.
    (Peptide available as ab46898)

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.40
    Preservative: 0.02% Sodium azide
    Constituent: PBS

    Batches of this product that have a concentration
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Epigenetics and Nuclear Signaling
    • Transcription
    • Domain Families
    • Zinc Finger
    • Signal Transduction
    • Signaling Pathway
    • Nuclear Signaling
    • Nuclear Hormone Receptors
    • Retinoic & Retinoid
    • Epigenetics and Nuclear Signaling
    • Nuclear Signaling Pathways
    • Nuclear Receptors
    • Retinoic & Retinoid
    • Cancer
    • Signal transduction
    • Nuclear signaling
    • Nuclear hormone receptors
    • Retanoic and retanoid
    • Cancer
    • Cancer Metabolism
    • Response to hypoxia
    • Metabolism
    • Pathways and Processes
    • Metabolism processes
    • Hypoxia
    • Metabolism
    • Types of disease
    • Cancer

Associated products

  • Compatible Secondaries

    • Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
    • Goat Anti-Rabbit IgG H&L (HRP) (ab205718)
  • Immunizing Peptide (Blocking)

    • Human PML+RARA Fusion peptide (ab46898)
  • Isotype control

    • Rabbit IgG, polyclonal - Isotype Control (ChIP Grade) (ab171870)

Applications

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab43152 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Guaranteed

Tested applications are guaranteed to work and covered by our Abpromise guarantee.

Predicted

Predicted to work for this combination of applications and species but not guaranteed.

Incompatible

Does not work for this combination of applications and species.

Application Species
WB
Human
Application Abreviews Notes
WB (1)
Use at an assay dependent concentration. Predicted molecular weight: 98 kDa.
Notes
WB
Use at an assay dependent concentration. Predicted molecular weight: 98 kDa.

Target

  • Relevance

    PML protein is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. Retinoic acid, a metabolite of vitamin A, is necessary for normal organogenesis but acts as a teratogen at high levels during embryonic and fetal development. Retinoic acid functions through its interaction with the nuclear protein, retinoic acid receptor (RAR). RAR belongs to the steroid and thyroid hormone superfamily of nuclear receptor proteins which exert their effects by binding to specific DNA response elements, thus regulating gene expression in target cells. RAR exists as three major subtypes: alpha, beta and gamma.
  • Cellular localization

    Nuclear and Cytoplasmic
  • Database links

    • Entrez Gene: 5371 Human
    • Entrez Gene: 5914 Human
    • Omim: 102578 Human
    • Omim: 180240 Human
    • SwissProt: P10276 Human
    • SwissProt: P29590 Human
    • Alternative names

      • MYL antibody
      • NR1B1 antibody
      • Nuclear receptor subfamily 1 group B member 1 antibody
      • Nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR long form antibody
      • PP8675 antibody
      • Promyelocytic leukemia antibody
      • Promyelocytic leukemia protein antibody
      • Promyelocytic leukemia, inducer of antibody
      • RAR antibody
      • RAR-alpha antibody
      • RARA alpha antibody
      • RARAalpha1 antibody
      • Retinoic acid receptor alpha polypeptide antibody
      • Retinoic acid receptor, alpha antibody
      • RING finger protein 71 antibody
      • RNF71 antibody
      • TRIM19 antibody
      • Tripartite motif protein TRIM19 antibody
      • Tripartite motif-containing protein 19 antibody
      see all

    Images

    • Western blot - Anti-PML+RARA Fusion antibody (ab43152)
      Western blot - Anti-PML+RARA Fusion antibody (ab43152)Image courtesy of Christian Marx (University of Jena, Germany)

      Anti-PML+ RARα Fusion antibody (ab43152) reactivity with reduced NB4 (A and B) and K562 (B) cell lysate. After SDS-PAGE (where 100μg lysate was loaded in A and 20μg lysate in B), membranes were blocked in 5% Milk in PBS + 0.1% Tween for 1h at 25°C before incubation with ab43152 (1:5,000 dilution in 1% Milk PBS + 0.1% Tween) for 16h at 4ºC. Blots was then incubated with an anti-Rabbit HRP-conjugated secondary antibody before developing with ECL.

    Protocols

    To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

    Click here to view the general protocols

    Datasheets and documents

    • Datasheet
  • References (8)

    Publishing research using ab43152? Please let us know so that we can cite the reference in this datasheet.

    ab43152 has been referenced in 8 publications.

    • Kumar S & Tchounwou PB Trisenox Disrupts MDM2-DAXX-HAUSP Complex and Induces Apoptosis in a Mouse Model of Acute Leukemia. J Cancer 11:4373-4383 (2020). PubMed: 32489456
    • Rejlova K  et al. Low HOX gene expression in PML-RARa-positive leukemia results from suppressed histone demethylation. Epigenetics 13:73-84 (2018). PubMed: 29224413
    • Kumar S  et al. Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells. Oncotarget 9:33138-33148 (2018). PubMed: 30237857
    • Li K  et al. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARa and Inhibition of p53-Mediated Senescence. Cancer Cell 31:697-710.e7 (2017). PubMed: 28486108
    • Li X  et al. Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line. J Int Med Res 44:882-92 (2016). PubMed: 27189198
    • Hennig D  et al. Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells. Br J Cancer 112:329-37 (2015). WB . PubMed: 25514379
    • Ying M  et al. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARa/STAT1 axis. Mol Cancer Ther 12:195-206 (2013). WB ; Human . PubMed: 23243061
    • Guo Y  et al. Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RAR{alpha} and Inhibits the Growth of Acute Promyelocytic Leukemia. Cancer Res 70:9875-85 (2010). WB ; Human . PubMed: 20935222

    Images

    • Western blot - Anti-PML+RARA Fusion antibody (ab43152)
      Western blot - Anti-PML+RARA Fusion antibody (ab43152) Image courtesy of Christian Marx (University of Jena, Germany)

      Anti-PML+ RARα Fusion antibody (ab43152) reactivity with reduced NB4 (A and B) and K562 (B) cell lysate. After SDS-PAGE (where 100μg lysate was loaded in A and 20μg lysate in B), membranes were blocked in 5% Milk in PBS + 0.1% Tween for 1h at 25°C before incubation with ab43152 (1:5,000 dilution in 1% Milk PBS + 0.1% Tween) for 16h at 4ºC. Blots was then incubated with an anti-Rabbit HRP-conjugated secondary antibody before developing with ECL.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-NGF antibody [EP1320Y] (ab52918)

    •  
    • Product image

      Anti-Cardiac Troponin T antibody [EPR3695] (ab91605)

    •  
    • Product image

      Anti-Cyclin H/p34 antibody [EPR3929] (ab92376)

    •  
    • Product image

      Anti-SOX18 antibody [EPR2837(2)] (ab109194)

    •  
    • Product image

      Anti-eIF4A2 antibody (ab31218)

    •  
    • Product image

      Anti-TLT-1 antibody [EP15294] (ab192619)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.